Epitope Detection in Monocytes (EDIM) As a New Method of Liquid Biopsy in Pediatric Rhabdomyosarcoma.
Apo10
EDIM
TKTL1
pediatric rhabdomyosarcoma
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
28 Jul 2022
28 Jul 2022
Historique:
received:
19
03
2022
revised:
20
07
2022
accepted:
26
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Biomarkers allowing characterization of pediatric rhabdomyosarcoma (RMS) are lacking. Epitope detection in monocytes (EDIM) is a novel method focused on detection of the biomarkers TKTL1 (transketolase-like protein 1) and Apo10 (epitope of DNaseX) in activated monocytes (CD14
Identifiants
pubmed: 36009359
pii: biomedicines10081812
doi: 10.3390/biomedicines10081812
pmc: PMC9404738
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Madeleine Schickedanz Stiftung
ID : Not applicable
Organisme : Open Access Publishing Fund of Tuebingen University
ID : Not applicable
Références
Pediatr Blood Cancer. 2013 Aug;60(8):1267-73
pubmed: 23418028
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Blood. 1993 Sep 15;82(6):1820-8
pubmed: 8104532
Genome Biol. 2014 Feb 20;15(2):R37
pubmed: 24555846
BMC Cancer. 2016 Feb 22;16:134
pubmed: 26907172
Oncol Rep. 2007 Apr;17(4):841-5
pubmed: 17342325
BMC Cancer. 2011 Aug 19;11:363
pubmed: 21854597
Clin Oral Investig. 2016 Mar;20(2):329-38
pubmed: 26153867
Int J Mol Sci. 2017 Apr 20;18(4):
pubmed: 28425973
Oral Maxillofac Surg. 2016 Sep;20(3):295-302
pubmed: 26875085
Prostate. 2005 Feb 15;62(3):290-8
pubmed: 15389786
Eur Arch Otorhinolaryngol. 2007 Dec;264(12):1431-6
pubmed: 17639446
Future Oncol. 2012 Oct;8(10):1349-59
pubmed: 23130932
PLoS One. 2009;4(3):e4961
pubmed: 19305507
J Clin Oncol. 1999 Dec;17(12):3706-19
pubmed: 10577842
Prostate. 2017 Sep;77(12):1251-1258
pubmed: 28726251
Biochim Biophys Acta. 2010 Jan;1805(1):105-17
pubmed: 19931353
Biochemistry. 2000 Jun 27;39(25):7365-73
pubmed: 10858283
Clin Cancer Res. 2010 Feb 1;16(3):857-66
pubmed: 20103683
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6
pubmed: 8790415
Cancer Res. 2005 Mar 15;65(6):2115-24
pubmed: 15781621
Nat Rev Cancer. 2004 Feb;4(2):143-53
pubmed: 14732866
Pathology. 2011 Dec;43(7):719-24
pubmed: 22027741
Nat Commun. 2019 Jun 7;10(1):2502
pubmed: 31175280
Semin Pediatr Surg. 2016 Oct;25(5):276-283
pubmed: 27955730
Pediatr Blood Cancer. 2022 Sep;69(9):e29652
pubmed: 35338758
Biotechniques. 2007 Nov;43(5):575, 577-8, 581-2 passim
pubmed: 18072586
Cell Physiol Biochem. 2017;41(2):755-768
pubmed: 28214887
Anticancer Res. 2009 Aug;29(8):3245-51
pubmed: 19661342
Br J Cancer. 2006 Feb 27;94(4):578-85
pubmed: 16465194
Anticancer Drugs. 2007 Apr;18(4):427-33
pubmed: 17351395
BMC Cancer. 2013 Dec 04;13:569
pubmed: 24304513
Acta Odontol Scand. 2015 Jul;73(5):336-42
pubmed: 25234444
Int J Oncol. 2020 Jul;57(1):289-300
pubmed: 32377699
J Pediatr Surg. 2006 Apr;41(4):633-8; discussion 633-8
pubmed: 16567168
Cancer Biomark. 2020;27(1):129-137
pubmed: 31771043
Future Oncol. 2013 Apr;9(4):605-9
pubmed: 23560382
Cancer Res. 2006 Oct 1;66(19):9401-7
pubmed: 17018594
Oncotarget. 2016 Aug 9;7(32):51875-51897
pubmed: 27391434
Cancer Biol Ther. 2016;17(2):163-8
pubmed: 26650256
Cancer Biomark. 2015;15(5):591-7
pubmed: 26406948
Cancer. 1992 Nov 15;70(10):2557-67
pubmed: 1482503
Cancer Metastasis Rev. 2019 Dec;38(4):553-571
pubmed: 31836951